McKesson Corporation

NYSE:MCK

Medical - Distribution

Healthcare
$1,084.43 -3.71%

-$28.96 today

Market cap
$125.21B
Beta
0.32
P/E (TTM)
19.3
EPS (TTM)
$39.00
Dividend yield
0.44%
52W Low $637.00High $999.00

Volume 0.67M

Average 1.03M

MCK Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

McKesson CorporationNYSE: MCK

Cost of Revenue · Q1 FY2027 · quarter ended Jun 2026

Cost of revenue grows in line with its trailing trend

Q1 FY2027 cost of revenue of $101.7B rose 7.6% year over year, behind the +8.5% change in trailing-twelve-month cost of revenue. Sequentially, it rose 10.2% from the prior quarter. Over 3 fiscal years it compounded at +13.7% a year.

Context

  • Cost of revenue amounted to 96.4% of revenue in FY2026, down 0.1 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +7.6% toward the trailing-twelve-month pace of +8.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$101.7B+10.2% QoQ
Last fiscal yearMar 2026
$388.88B+12.2% YoY
LTMJun 2026
$396.03B+8.5% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.6%——
1 year+12.2%——
3-year CAGR+13.7%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2026
388.88B USD
Year-over-year change
+12.2%
4-year CAGR
+11.5%

Cost of Revenue vs competitors

How MCK compares with its peers on the latest reported figures

  • MCK's LTM Jun 2026 cost of revenue of $396.03B is the highest of the 4 companies compared; the peer median is $247.7B.
  • Its year-over-year change of +8.5% is the 2nd highest of 4, against a peer median of +4.4%.
  • Cost of revenue amounts to 96.4% of revenue for MCK, versus a peer median of 96.1%.
MCK Competitors Peer median
Cost of Revenue for MCK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MCKMcKesson CorporationLTM Jun 2026$396.03B +8.5%+13.7%96.4%
CORCencora, Inc.LTM Jun 2026$320.43B +4.4%+10.4%96.3%
CAHCardinal Health, Inc.LTM Sep 2026$247.7B +9.7%+7.3%96.1%
ACHAccendra Health, Inc.LTM Mar 2026$1.59B -67.6%-42.3%58.7%
Peer median (excluding MCK) $247.7B+4.4%+7.3%96.1%

Competitors are the stored peer set for MCK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue263.97B276.71B308.95B359.05B403.43B
Cost of Revenue251.32B264.84B296.75B346.57B388.88B
Gross Profit12.65B11.87B12.2B12.49B14.55B
Gross Margin4.8%4.3%3.9%3.5%3.6%
Research & Development70M89M77M91M103M
Selling, General & Admin9.86B7.33B8.2B8.02B(8.1B)
Operating Expenses9.93B7.42B8.28B8.11B8.1B
Depreciation & Amortization760M608M635M636M729M
EBITDA2.87B5.49B4.67B5.25B7.18B
EBITDA Margin1.1%2.0%1.5%1.5%1.8%
Operating Income2.72B4.45B3.93B4.37B6.45B
Operating Margin1.0%1.6%1.3%1.2%1.6%
Interest Income10M107M118M173M179M
Interest Expense178M248M243M256M247M
Other Income / Expenses(795M)177M(138M)(13M)(253M)
Income Before Tax1.93B4.63B3.79B4.36B6.2B
Pre-Tax Margin0.7%1.7%1.2%1.2%1.5%
Income Tax Expense636M905M629M878M1.1B
Net Income1.11B3.56B3B3.3B4.76B
Net Margin0.4%1.3%1.0%0.9%1.2%
EPS (Basic)7.3125.2322.5425.8638.55
EPS (Diluted)7.2325.0422.3925.7238.38
Weighted Avg Shares152.3M141.1M133.2M127.4M123.6M
Weighted Avg Shares (Diluted)154.1M142.2M134.1M128.1M124.1M

McKesson Corporation

NYSE:MCK

Intrinsic Alpha fair value

Locked

Current Price

$1,084.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.